Clinical Trials Logo

Brain Tumors clinical trials

View clinical trials related to Brain Tumors.

Filter by:

NCT ID: NCT02890940 Completed - Quality of Life Clinical Trials

Bridging the Gap: Using Video Art to Document the Human Face of Disease & Predict Quality of Life Assessments in Brain Tumor Patients

Start date: August 2016
Phase: N/A
Study type: Interventional

The goal of this study is to explore whether facial expression changes in visual portraits correlate with Quality of Life (QOL) questionnaire responses before and after pet therapy sessions and to compare scores of QOL questionnaires before and after pet therapy.

NCT ID: NCT02846038 Active, not recruiting - Solid Tumor Clinical Trials

Understanding Communication in Healthcare to Achieve Trust (U-CHAT)

Start date: September 9, 2016
Phase:
Study type: Observational

Honest, clear, and empathetic communication between pediatric oncologists (POs) and parents of children with cancer (POCCs) is imperative to facilitating therapeutic alliance and ensuring that medical management aligns with the families' goals of care. Communication is particularly important during conversations about disease reevaluation, which often necessitate parental decision-making in the context of emotional distress. POs employ a spectrum of communication styles and strategies during challenging conversations, and there is no consensus regarding linguistic or thematic metrics for high quality communication of upsetting information. In order to better understand how POs communicate difficult information to POCCs, the investigators propose a pilot study designed to accomplish the following primary aim: Primary Objective: - To identify recurrent verbal and nonverbal (e.g. the use of pauses/silence) communication techniques employed by POs in the delivery of difficult prognostic information to POCCs through content analysis of audio-recorded conversations between POs and parents of children with high risk cancer at the time of disease reevaluation. The study expects to enroll up to: 80 patient participants, 80 parents, and 15 primary pediatric oncologists (total = 175). Non-primary oncologist members of the clinical care team, extended family members, or friends of the family may also participate, if they choose to do so.

NCT ID: NCT02824731 Recruiting - Brain Tumors Clinical Trials

Comparison of Proton and Photon Radiotherapy of Brain Tumors (ProtoChoice-Hirn)

Start date: July 2016
Phase: N/A
Study type: Interventional

This protocol compares the toxicity of radiotherapy or radiochemotherapy applied with different radiation modalities - protons or photons. Patients with different kinds of brain tumours and foreseen high-dose radiotherapy can be included. The hypothesis of the trial is that the rate of chronic toxicity 1 year after the end of radiotherapy is 15% lower after proton compared to photon treatment.

NCT ID: NCT02712476 Completed - Brain Tumors Clinical Trials

Brain Relaxation With Mannitol and Furosemide

Start date: July 2013
Phase: N/A
Study type: Interventional

Although mannitol is used for brain relaxation during neurosurgery and in the treatment of raised intracranial pressure; there is not a consensus on its safe and effective dose, the duration of its administration and its use in combination with loop diuretics. This study aimed to compare the effects of the mannitol alone and in combination with furosemide in different doses, on the brain relaxation, electrolyte, lactate levels of the blood, peroperative fluid balance and the volume of the urine in supratentorial mass resection surgeries. This prospective, randomized, double blind, placebo controlled study included fifty one patients (ASA I-III) scheduled for elective supratentorial mass resection surgery. The patients were randomized into three groups for investigation of the effects of mannitol alone and in combination with furosemide in different doses. Blood sodium, potassium, chlorine, lactate, urine and osmolarity levels were recorded. The brain relaxation score (BRS) was evaluated twice by the surgeon using a 4 point scale (1=very good, 2=good, 3=bad, 4=very bad); at dura opening, and 30 minutes after the administration of the study drug.

NCT ID: NCT02670161 Enrolling by invitation - Stroke Clinical Trials

Quality Improvement and Practice Based Research in Neurology Using the EMR

Start date: May 2016
Phase: Phase 4
Study type: Interventional

The investigators will conduct at NorthShore University HealthSystem pragmatic trials using the EMR for 10 common neurological disorders. They will demonstrate the feasibility of subgroup based adaptive assignment of treatments, electronic consenting, and outcomes data capture at the point of care using the EMR. They will identify the most effective treatments for common neurological disorders and seek replication by the NPBRN.

NCT ID: NCT02649699 Completed - Brain Tumors Clinical Trials

Multi-Parametric Brain Cancer MRI

Start date: April 14, 2016
Phase: N/A
Study type: Interventional

The purpose of this pilot study is to test new magnetic resonance imaging (MRI) acquisition and processing techniques on primary brain tumor patients. The objectives are to improve image-guided radiation therapy (IGRT) planning (first part of the study) and treatment monitoring (second part).

NCT ID: NCT02537106 Completed - Brain Tumors Clinical Trials

A Comparison of the Effect of 1.5 Versus 3% NaCl on Brain Relaxation and Microcirculation

Start date: September 2015
Phase: N/A
Study type: Interventional

Hyperosmotic solutions of 1.5% and 3% NaCl are equally effective for brain relaxation and microcirculation during brain surgery. The effect of 1.5% NaCl on postoperative natremia and natriuresis is less pronounced.

NCT ID: NCT02530749 Completed - Brain Tumors Clinical Trials

Frailty as a Predictor of Neurosurgical Outcomes in Brain Tumor Patients

Start date: April 2014
Phase:
Study type: Observational

Frailty as an adjunct to preoperative assessment of neurosurgical patients has never been evaluated. This study aims to determine if frailty predicts neurosurgical complications in brain tumor patients and enhances current perioperative risk models.

NCT ID: NCT02489071 Completed - Brain Tumors Clinical Trials

Cognitive Intervention After a Brain Tumor

Start date: August 2014
Phase: N/A
Study type: Interventional

This study evaluates the feasibility and utility of two behavioural programs designed to reduce cognitive impairments secondary to brain tumors and/or their treatment. One-third of participants will complete training in either program, with the remaining third a wait-list control group.

NCT ID: NCT02452216 Completed - Brain Cancer Clinical Trials

Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS

Start date: June 10, 2015
Phase: Early Phase 1
Study type: Interventional

This pilot clinical trial study will assess the inflammatory response of brain tumors or other central nervous system conditions in pediatric and adult patients using ferumoxytol-enhanced MRI. Imaging features will be correlated with the number of inflammatory cells (macrophages) at histopathology. Determining the extent of inflammation associated with pathologies in the central nervous system may be helpful for diagnostic and prognostic purposes as well as monitoring treatment response of current and future immunotherapies.